|
|
||||||
|
|
|
|
|
|
|
 |
 |
|
 |
|
|
LITHOBID® (lithium carbonate) is an extended-release formulation containing 300mg of lithium carbonate. LITHOBID is indicated in the treatment of manic episodes of Bipolar Disorder. Bipolar Disorder, Manic (DSM-IV) is equivalent to Manic Depressive illness, Manic, in the older DSM-II terminology. LITHOBID is also indicated as a maintenance treatment for individuals with a diagnosis of Bipolar Disorder. Maintenance therapy reduces the frequency of manic episodes and diminishes the intensity of those episodes which may occur. |
|
||||
 |
|
||||
 |
|
||||
|
 |
|
|||
|
|
||||
The LITHOBID ® (lithium carbonate) Patient Assistance Program ended December 31, 2009. Click Here for more information.
|
You are encouraged to report negative side effects of prescription drugs to the FDA. Legal Notices | Privacy Statement | Contact Us |
